Australia's largest stock trading and investment forum Australia's #1 stock forum

AXE archer materials limited

0.00%

23.0¢

Ann: Early-stage assembly of biochip components, page-29

First 29 Last

Share
Profile

Follow
whytee

17,570 Posts.

2522

04/11/21

14:09

Post #: 57316316
Share

Originally posted by flammo ↑

Yes, the competitors don't exist yet. This bypasses the need for sending a sample off to a lab, and waiting 12 hours to 1 week for a test result. The test can be done at the GP, you don't need to go elsewhere to get the sample taken, you don't need to go to a lab, and you don't then need to wait for the GP to tell you the result or pay for another GP appointment to go and discuss the result. The result will be instantaneous and right there.

Expand

LoL, of course they exist.
One example

https://www.woodleyequipment.com/product/76/i-STAT-Portable-Clinical-Analyser

Not sure where the "nano" label comes from, the channels are 20 microns.
As compared to semiconductor manufacturing which is several orders of magnitude smaller at 5nm

Last edited by whytee: 04/11/21

AXE Price at posting: $1.69 Sentiment: Hold Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 29 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 23.0¢		Change 0.000(0.00%)		Mkt cap ! $58.61M

Open	High	Low	Value	Volume
22.5¢	24.0¢	22.5¢	$89.25K	387.4K

Buyers (Bids)

No.	Vol.	Price($)
4	104441	23.0¢

Sellers (Offers)

Price($)	Vol.	No.
23.5¢	56023	2

View Market Depth

No.	Vol.	Price($)
4	104441	0.230
9	184295	0.225
13	248602	0.220
7	58193	0.215
8	164657	0.210

Price($)	Vol.	No.
0.235	56023	2
0.240	101099	4
0.245	7000	1
0.250	76000	3
0.255	129000	3

Last trade - 16.10pm 27/06/2025 (20 minute delay)

AXE (ASX) Chart

Ann: Early-stage assembly of biochip components, page-29

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Early-stage assembly of biochip components, page-29

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News